Skip to main content
Journal of Patient-Reported Outcomes

Table 3 Cronbach’s alpha for FACT-GOG-Ntx and FACT-GOG-Ntx-4 by rater over time

From: Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study

 

Time 1

(Baseline)

Time 2

(D8, Cycle 2)

Time 3

(D8, Cycle 5)

FACT-GOG-Ntx

   

 Youth

0.76

0.81

0.88

 Parent-Proxy

0.71

0.80

0.90

FACT-GOG-Ntx-4

   

 Youth

0.67

0.75

0.85

 Parent-Proxy

0.81

0.79

0.87

  1. Youth report is for patients aged 11 to 21.9 years; parent-proxy report is for youth aged 5 to 17.9 years
Back to article page